Skip to main content
Top
Published in: Annals of Nuclear Medicine 4/2010

01-05-2010 | Original Article

Tumor grade-related thallium-201 uptake in chondrosarcomas

Authors: G. Capa Kaya, Y. Demir, S. Ozkal, T. Sengoz, M. Manisalı, O. Baran, M. Koc, B. Tuna, D. Ozaksoy, H. Havıtcıoglu

Published in: Annals of Nuclear Medicine | Issue 4/2010

Login to get access

Abstract

Objectives

Diagnosis of low-grade chondrosarcoma, especially discrimination between enchondroma and low-grade chondrosarcoma, may be difficult pathologically. The aim of this study was to evaluate the value of thallium-201 (Tl-201) scintigraphy in the diagnosis of chondrosarcoma and to investigate whether there was a correlation between Tl-201 uptake and tumor grade.

Methods

We retrospectively evaluated 121 patients with pathologically proven bone and soft tissue tumors diagnosed between the years 1999 and 2007. All patients were followed by the Bone and Soft Tissue Tumor Working Group in our hospital. Twenty-three patients, mean age 44 ± 15 (range 17–72) years, with a diagnosis of cartilaginous tumors were included. Increased Tl-201 uptake at the lesion sites greater than background was evaluated as malignant tumor. For the pathologic classification, a grading system (grade 1–3) based on the histopathologic findings was used. Pearson correlation coefficient was used to determine whether there was any correlation between Tl-201 uptake and tumor grade in chondrosarcoma.

Results

There were 7 enchondromas and 16 chondrosarcomas. Four of 16 patients with chondrosarcoma had lesions pathologically classified as grade 3, 5 as grade 2, and 7 had grade 1 chondrosarcoma. Increased Tl-201 uptake was observed in all patients with grade 3 chondrosarcoma and 2 patients with grade 2 chondrosarcoma. Of 10 patients with chondrosarcoma, 3 grade 2 chondrosarcomas and 7 grade 1 chondrosarcomas, there was no Tl-201 uptake in the tumor region. A significant correlation was found between Tl-201 uptake and tumor grade in chondrosarcoma (p = 0.002, r = 0.71). Only a few reports in literature have demonstrated false negative results in low-grade chondrosarcoma.

Conclusion

Tl-201 uptake was related to tumor grade in chondrosarcoma. If there is a possibility of chondrosarcoma, Tl-201 scintigraphy should be reported with caution.
Literature
1.
go back to reference Higuchi T, Taki J, Sumiya H, et al. Characterization of cartilaginous tumors with 201Tl scintigraphy. Ann Nucl Med. 2005;19(2):95–9.CrossRefPubMed Higuchi T, Taki J, Sumiya H, et al. Characterization of cartilaginous tumors with 201Tl scintigraphy. Ann Nucl Med. 2005;19(2):95–9.CrossRefPubMed
2.
go back to reference Campanacci M. Bone and soft tissue tumors. 2nd ed. Wien: Springer; 1999. p. 213–319. Campanacci M. Bone and soft tissue tumors. 2nd ed. Wien: Springer; 1999. p. 213–319.
3.
go back to reference Brenner W, Conrad EU, Eary JF. FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients. Eur J Nucl Med Mol Imaging. 2004;31:189–95.CrossRefPubMed Brenner W, Conrad EU, Eary JF. FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients. Eur J Nucl Med Mol Imaging. 2004;31:189–95.CrossRefPubMed
4.
go back to reference Aoki J, Watanabe H, Shinozaki T, et al. FDG-PET in differential diagnosis and grading of chondrosarcomas. J Comput Assist Tomogr. 1999;23:603–8.CrossRefPubMed Aoki J, Watanabe H, Shinozaki T, et al. FDG-PET in differential diagnosis and grading of chondrosarcomas. J Comput Assist Tomogr. 1999;23:603–8.CrossRefPubMed
5.
go back to reference Eary JF, Conrad EU, Bruckner JD, et al. Quantitative (F-18) fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma. Clin Cancer Res. 1998;4:1215–20.PubMed Eary JF, Conrad EU, Bruckner JD, et al. Quantitative (F-18) fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma. Clin Cancer Res. 1998;4:1215–20.PubMed
6.
go back to reference Poddof DA. Thallium-201 chloride and technetium-99m sestamibi imaging. In: Henkin R, Boles MA, Dillehay GI, Halama JR, Karesh SM, Wagner RH, Zimmer AM, editors. Nuclear medicine. St Louis: Mosby-Year Book; 1996. p. 1493–503. Poddof DA. Thallium-201 chloride and technetium-99m sestamibi imaging. In: Henkin R, Boles MA, Dillehay GI, Halama JR, Karesh SM, Wagner RH, Zimmer AM, editors. Nuclear medicine. St Louis: Mosby-Year Book; 1996. p. 1493–503.
7.
go back to reference Degirmenci B, Havıtcıoglu H, Derebek E, et al. Thallium-201 and three phase bone scintigraphy in the evaluation of bone and soft tissue sarcomas. TJNM. 1997;6:100–4. Degirmenci B, Havıtcıoglu H, Derebek E, et al. Thallium-201 and three phase bone scintigraphy in the evaluation of bone and soft tissue sarcomas. TJNM. 1997;6:100–4.
8.
go back to reference Maini JL, Tofani A, Sciuto R, et al. The role of Tl-201 scintigraphy and chemotherapeutic response in rhabdomyosarcoma. Clin Nucl Med. 1994;19:607–10.CrossRefPubMed Maini JL, Tofani A, Sciuto R, et al. The role of Tl-201 scintigraphy and chemotherapeutic response in rhabdomyosarcoma. Clin Nucl Med. 1994;19:607–10.CrossRefPubMed
9.
go back to reference Hans der Val MB, Murray PC, Huckstep RL, et al. The role of thallium scintigraphy in excluding malignancy in bone. Clin Nucl Med. 1993;18:551–7.CrossRef Hans der Val MB, Murray PC, Huckstep RL, et al. The role of thallium scintigraphy in excluding malignancy in bone. Clin Nucl Med. 1993;18:551–7.CrossRef
10.
go back to reference Ramanna L, Waxman A, Binney GO, et al. Thallium scintigraphy in bone sarcoma: comparison with Ga-67 and Tc-99m MDP in the evaluation of chemotherapeutic response. J Nucl Med. 1990;31:567–72.PubMed Ramanna L, Waxman A, Binney GO, et al. Thallium scintigraphy in bone sarcoma: comparison with Ga-67 and Tc-99m MDP in the evaluation of chemotherapeutic response. J Nucl Med. 1990;31:567–72.PubMed
11.
go back to reference Hasegawa T, Seki K, Yang P, et al. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone. Hum Pathol. 1995;26:838–45.CrossRefPubMed Hasegawa T, Seki K, Yang P, et al. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone. Hum Pathol. 1995;26:838–45.CrossRefPubMed
12.
go back to reference Ishida T, Kikuchi F, Machinami R. Histological grading and morphometric analysis of cartilaginous tumours. Virchows Arch A Pathol Anat Histopathol. 1991;418:149–55.CrossRefPubMed Ishida T, Kikuchi F, Machinami R. Histological grading and morphometric analysis of cartilaginous tumours. Virchows Arch A Pathol Anat Histopathol. 1991;418:149–55.CrossRefPubMed
13.
go back to reference Evans HL, Ayala AG, Romsdahl MM. Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer. 1977;40:818–31.CrossRefPubMed Evans HL, Ayala AG, Romsdahl MM. Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer. 1977;40:818–31.CrossRefPubMed
14.
go back to reference Büyükdereli G, Sargin O, Ozbarlas S. Tc-99m tetrofosmin imaging in chondrosarcoma. Clin Nucl Med. 2000;25:64–5.CrossRefPubMed Büyükdereli G, Sargin O, Ozbarlas S. Tc-99m tetrofosmin imaging in chondrosarcoma. Clin Nucl Med. 2000;25:64–5.CrossRefPubMed
15.
go back to reference Arsos G, Venizelos I, Karatzas N, et al. Low-grade chondrosarcomas: a difficult target for radionuclide imaging. Case report and review of the literature. Eur J Radiol. 2002;43:66–72.CrossRefPubMed Arsos G, Venizelos I, Karatzas N, et al. Low-grade chondrosarcomas: a difficult target for radionuclide imaging. Case report and review of the literature. Eur J Radiol. 2002;43:66–72.CrossRefPubMed
16.
go back to reference Murphey MD, Flemming DJ, Boyea SR, et al. Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features. Radiographics. 1998;18:1213–37.PubMed Murphey MD, Flemming DJ, Boyea SR, et al. Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features. Radiographics. 1998;18:1213–37.PubMed
17.
go back to reference Lee FY, Mankin HJ, Fondren G, et al. Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am. 1999;81:326–38.CrossRefPubMed Lee FY, Mankin HJ, Fondren G, et al. Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am. 1999;81:326–38.CrossRefPubMed
18.
go back to reference Feldman F, Van Heertum R, Saxena C, et al. 18FDG-PET applications for cartilage neoplasms. Skeletal Radiol. 2005;34:367–74.CrossRefPubMed Feldman F, Van Heertum R, Saxena C, et al. 18FDG-PET applications for cartilage neoplasms. Skeletal Radiol. 2005;34:367–74.CrossRefPubMed
19.
go back to reference Choong PF, Nizam I, Ngan SY, et al. Thallium-201 scintigraphy—a predictor of tumour necrosis in soft tissue sarcoma following preoperative radiotherapy? Eur J Surg Oncol. 2003;29:908–15.CrossRefPubMed Choong PF, Nizam I, Ngan SY, et al. Thallium-201 scintigraphy—a predictor of tumour necrosis in soft tissue sarcoma following preoperative radiotherapy? Eur J Surg Oncol. 2003;29:908–15.CrossRefPubMed
20.
go back to reference Lee FY, Yu J, Chang SS, et al. Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone. Bone Joint Surg Am. 2004;86:2677–85. Lee FY, Yu J, Chang SS, et al. Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone. Bone Joint Surg Am. 2004;86:2677–85.
21.
go back to reference Ionidis JP, Lau J. 18F-FDG PET for the diagnosis and grading of soft tissue sarcoma: a meta-analysis. J Nucl Med. 2003;44:717–24. Ionidis JP, Lau J. 18F-FDG PET for the diagnosis and grading of soft tissue sarcoma: a meta-analysis. J Nucl Med. 2003;44:717–24.
22.
go back to reference Menendez LR, Fideler BM, Mirra J. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy. J Bone Joint Surg Am. 1993;75:526–31.PubMed Menendez LR, Fideler BM, Mirra J. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy. J Bone Joint Surg Am. 1993;75:526–31.PubMed
23.
go back to reference Imbriaco M, Yeh SD, Yeung H, et al. Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma. Cancer. 1997;80:1507–12.CrossRefPubMed Imbriaco M, Yeh SD, Yeung H, et al. Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma. Cancer. 1997;80:1507–12.CrossRefPubMed
24.
go back to reference Ohtoma K, Terui S, Yokoyama R, et al. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma. J Nucl Med. 1996;37:1444–8. Ohtoma K, Terui S, Yokoyama R, et al. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma. J Nucl Med. 1996;37:1444–8.
Metadata
Title
Tumor grade-related thallium-201 uptake in chondrosarcomas
Authors
G. Capa Kaya
Y. Demir
S. Ozkal
T. Sengoz
M. Manisalı
O. Baran
M. Koc
B. Tuna
D. Ozaksoy
H. Havıtcıoglu
Publication date
01-05-2010
Publisher
Springer Japan
Published in
Annals of Nuclear Medicine / Issue 4/2010
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-010-0361-2

Other articles of this Issue 4/2010

Annals of Nuclear Medicine 4/2010 Go to the issue